Update on Risankizumab for Psoriasis Jennifer C. BaresMark G. Lebwohl Psoriasis (J Wu, Section Editor) 18 January 2019 Pages: 1 - 5
Tildrakizumab for Moderate-to-Severe Chronic Plaque Psoriasis: a Review of the Literature Kory P. SchromAvi BittermanNeil J. Korman Psoriasis (J Wu, Section Editor) 16 January 2019 Pages: 6 - 13
Nanotechnology for Psoriasis Therapy Emily C. MurphySamuel W. SchaffterAdam J. Friedman Psoriasis (J Wu, Section Editor) 30 January 2019 Pages: 14 - 25
Biosimilars for Psoriasis—Experience from Europe Arnon D. CohenTiago TorresHelen Young Invited Commentary 07 February 2019 Pages: 26 - 34